Guidance Capital »

Amphastar Pharmaceuticals shares owned by Guidance Capital

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by Guidance Capital from 13F filings

Historical chart of Guidance Capital investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by Guidance Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by Guidance Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $343k 8.4k 40.78
2023-12-31 $466k 7.5k 62.29
2023-09-30 $321k 7.2k 44.87
2023-06-30 $377k 6.9k 54.69

More positions owned by Guidance Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Short Treas Bd (SHV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Invesco Actively Managed Etf Ultra Shrt Dur (GSY)
Ishares Tr Blackrock Ultra (ICSH)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Ishares Silver Tr Ishares (SLV)
Microsoft Corporation (MSFT)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Div Grwth (DGRO)

View all positions for Guidance Capital

Top funds holding Amphastar Pharmaceuticals

Federated Investors
Vanguard Group
Neuberger Berman Group
Dimensional Fund Advisors
TD Asset Management
T. Rowe Price Associates
Boone Capital Management
Charles Schwab Investment Management
Oberweis Asset Management
Nordea Investment Management Ab
Bessemer
LSV Asset Management
Bank of New York Mellon
Mesirow Institutional Investment Management
Victory Capital Management

View all funds holding Amphastar Pharmaceuticals